Amplify Weight Loss Drug & Treatment ETF
THNR
2 hedge funds and large institutions have $727K invested in Amplify Weight Loss Drug & Treatment ETF in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
23.23% more ownership
Funds ownership: 0% → 23.23% (+23%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$545K |
| 2 |
HI
Harbour Investments
Madison,
Wisconsin
|
+$171K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $553K | +$545K | +21,209 | New |
|
|
HI
2
Harbour Investments
Madison,
Wisconsin
| $174K | +$171K | +6,668 | New |
|
THNR Hedge Fund Activity: Q2 2024 in Review
2 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Amplify Weight Loss Drug & Treatment ETF (THNR) for Q2 2024, worth a combined $727K.
Buyers outnumbered sellers: 2 funds opened new THNR positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $545K.
- 2 institutional investors held Amplify Weight Loss Drug & Treatment ETF (THNR) as of Q2 2024, up from 0 in Q1 2024.
- Funds reported $727K of Amplify Weight Loss Drug & Treatment ETF stock for Q2 2024.
- 2 funds opened new Amplify Weight Loss Drug & Treatment ETF positions in Q2 2024 and 0 closed out, a net change of +2 holders.
- The largest Amplify Weight Loss Drug & Treatment ETF buyer in Q2 2024 was Jane Street, an estimated $545K added.
Based on aggregated 13F filings for Q2 2024.